London Daily

Focus on the big picture.
Wednesday, Oct 22, 2025

Science is Hong Kong’s best weapon to allay vaccine fears

Science is Hong Kong’s best weapon to allay vaccine fears

Worries about the effects of a vaccine are understandable. The government must respond with empathy, and correct and up-to-date information about the vaccines, especially the Chinese-made ones that have been the target of malicious rumours.

For almost a year, the world has been reeling from the Covid-19 pandemic. Now, it appears we are beginning to see light at the end of the tunnel, with Britain and the United States administrating the first shots of a vaccine developed by the American pharmaceutical giant Pfizer with Germany’s BioNTech.

Many governments around the world plan to inoculate their residents with Covid-19 vaccines, including Hong Kong’s. The Carrie Lam administration has announced procurement agreements with three pharmaceutical companies. One is mainland-based Sinovac Biotech, which will provide a million doses in January. The other two are China’s Fosun Pharma, which will supply the Pfizer-BioNTech vaccine, and the UK’s AstraZeneca.

Unfortunately, the Sinovac vaccine has been the subject of heated debate and even malicious attacks, especially on social media.

Denouncing what she sees as politicisation of the government’s procurement process, Chief Executive Carrie Lam Cheng Yuet-ngor stressed at a media briefing that the government’s decision to procure mainland-manufactured vaccines was based on scientific evidence.

It cannot be ruled out that the gossip surrounding the Sinovac vaccines is politically motivated, and any blatantly false or scientifically unfounded rumours must be corrected.

However, given the nature of Covid-19 and the accelerated vaccine development process, it is understandable that some people are hesitant, not only with regard to the Sinovac vaccine but also the others. Remember that even in an advanced country like the United States, there are many anti-vaxxers who oppose any kind of vaccination.

For starters, the full picture of this coronavirus is yet to be uncovered. It is unclear how long a vaccinated person will remain immune and whether there is a risk for a vaccinated person to transmit the virus. Moreover, while some vaccines have proved effective in trials, only time will tell if such results can be scaled up.

Furthermore, public concern about vaccine safety is understandable. For example, what are the side effects of getting a shot? The general public who lack medical knowledge may be frightened by news reports of participants suffering sickness during the clinical trials.


A health worker prepares to inoculate a volunteer with a Covid-19 vaccine produced by Sinopharm during its trial in Lima, Peru, on December 9. Peru temporarily suspended the clinical trials after detecting neurological problems in one of its test volunteers.


There were even recent reports of people in a vaccine trial experiencing facial paralysis, which were used by some people in Hong Kong to insinuate that Chinese-made vaccines had potential hazards. But the fact is, medical experts had already explained that this side effect is temporary and not severe as most people think.

In public relations, keeping stakeholders fully informed and updated about the matter in question is an effective way to prevent and extinguish harmful rumours. So the Hong Kong administration should launch a communication programme to give the public the objective facts about these vaccines.

To gain public trust in the forthcoming vaccination programme, the government needs to address scepticism and suspicion not just with empathy, but also professionalism and transparency, supported by up-to-date scientific data.

For example, the Hong Kong public should be informed that since the 2018 vaccine scandal involving Changchun Changsheng Biotechnology, the National Medical Products Administration (formerly the China Food and Drug Administration) has done a lot to clean up the vaccine sector. In fact, other countries have now signed agreements with China to procure Chinese-made vaccines.

The Hong Kong government should also allow people who wish to be vaccinated to choose the brand. Not giving people a he choice might raise more suspicions about Chinese-made vaccines.

Each Covid-19 vaccine has its own advantages and drawbacks. The Sinovac vaccine, for example, can be stored at regular fridge temperatures, which makes distribution easier, while the Pfizer-BioNTech vaccine has to be stored at minus 70 degrees Celsius.

Vaccines and widespread inoculation is undoubtedly the first step for world recovery. The benefits of herd immunity achieved through vaccination certainly outweigh personal concerns. The public must be provided with information on the benefits and risks associated with each procured vaccine, and allowed to come to an informed decision. Transparency is key.

Newsletter

Related Articles

0:00
0:00
Close
‘Frightening’ First Night in Prison for Sarkozy: Inmates Riot and Shout ‘Little Nicolas’
White House Announces No Imminent Summit Between Trump and Putin
US and Qatar Warn EU of Trade and Energy Risks from Tough Climate Regulation
Apple Challenges EU Digital Markets Act Crackdown in Landmark Court Battle
Nicolas Sarkozy begins five-year prison term at La Santé in Paris
Japan stocks surge to record as Sanae Takaichi becomes Prime Minister
This Is How the 'Heist of the Century' Was Carried Out at the Louvre in Seven Minutes: France Humiliated as Crown with 2,000 Diamonds Vanishes
China Warns UK of ‘Consequences’ After Delay to London Embassy Approval
France’s Wealthy Shift Billions to Luxembourg and Switzerland Amid Tax and Political Turmoil
"Sniper Position": Observation Post Targeting 'Air Force One' Found Before Trump’s Arrival in Florida
Shouting Match at the White House: 'Trump Cursed, Threw Maps, and Told Zelensky – "Putin Will Destroy You"'
Windows’ Own ‘Siri’ Has Arrived: You Can Now Talk to Your Computer
Thailand and Singapore Investigate Cambodian-Based Prince Group as U.S. and U.K. Sanctions Unfold
‘No Kings’ Protests Inflate Numbers — But History Shows Nations Collapse Without Strong Executive Power
Chinese Tech Giants Halt Stablecoin Launches After Beijing’s Regulatory Intervention
Manhattan Jury Holds BNP Paribas Liable for Enabling Sudanese Government Abuses
Trump Orders Immediate Release of Former Congressman George Santos After Commuting Prison Sentence
S&P Downgrades France’s Credit Rating, Citing Soaring Debt and Political Instability
Ofcom Rules BBC’s Gaza Documentary ‘Materially Misleading’ Over Narrator’s Hamas Ties
Diane Keaton’s Cause of Death Revealed as Pneumonia, Family Confirms
Former Lostprophets Frontman Ian Watkins Stabbed to Death in British Prison
"The Tsunami Is Coming, and It’s Massive": The World’s Richest Man Unveils a New AI Vision
Outsider, Heroine, Trailblazer: Diane Keaton Was Always a Little Strange — and Forever One of a Kind
Dramatic Development in the Death of 'Mango' Founder: Billionaire's Son Suspected of Murder
Two Years of Darkness: The Harrowing Testimonies of Israeli Hostages Emerging From Gaza Captivity
EU Moves to Use Frozen Russian Assets to Buy U.S. Weapons for Ukraine
Europe Emerges as the Biggest Casualty in U.S.-China Rare Earth Rivalry
HSBC Confronts Strategic Crossroads as NAB Seeks Only Retail Arm in Australia Exit
U.S. Chamber Sues Trump Over $100,000 H-1B Visa Fee
Shenzhen Expo Spotlights China’s Quantum Step in Semiconductor Self-Reliance
China Accelerates to the Forefront in Global Nuclear Fusion Race
Yachts, Private Jets, and a Picasso Painting: Exposed as 'One of the Largest Frauds in History'
Australia’s Wedgetail Spies Aid NATO Response as Russian MiGs Breach Estonian Airspace
McGowan Urges Chalmers to Cut Spending Over Tax Hike to Close $20 Billion Budget Gap
Victoria Orders Review of Transgender Prison Placement Amid Safety Concerns for Female Inmates
U.S. Treasury Mobilises New $20 Billion Debt Facility to Stabilise Argentina
French Business Leaders Decry Budget as Macron’s Pro-Enterprise Promise Undermined
Trump Claims Modi Pledged India Would End Russian Oil Imports Amid U.S. Tariff Pressure
Surging AI Startup Valuations Fuel Bubble Concerns Among Top Investors
Australian Punter Archie Wilson Tears Up During Nebraska Press Conference, Sparking Conversation on Male Vulnerability
Australia Confirms U.S. Access to Upgraded Submarine Shipyard Under AUKUS Deal
“Firepower” Promised for Ukraine as NATO Ministers Meet — But U.S. Tomahawks Remain Undecided
Brands Confront New Dilemma as Extremists Adopt Fashion Labels
The Sydney Sweeney and Jeans Storm: “The Outcome Surpassed Our Wildest Dreams”
Erika Kirk Delivers Moving Tribute at White House as Trump Awards Charlie Presidential Medal of Freedom
British Food Influencer ‘Big John’ Detained in Australia After Visa Dispute
ScamBodia: The Chinese Fraud Empire Shielded by Cambodia’s Ruling Elite
French PM Suspends Macron’s Pension Reform Until After 2027 in Bid to Stabilize Government
Orange, Bouygues and Free Make €17 Billion Bid for Drahi’s Altice France Telecom Assets
Dutch Government Seizes Chipmaker After U.S. Presses for Removal of Chinese CEO
×